0001209191-22-055080.txt : 20221101
0001209191-22-055080.hdr.sgml : 20221101
20221101171031
ACCESSION NUMBER: 0001209191-22-055080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221029
FILED AS OF DATE: 20221101
DATE AS OF CHANGE: 20221101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodgers Richard J
CENTRAL INDEX KEY: 0001313397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 221351386
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER ST., STE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-29
0
0001000694
NOVAVAX INC
NVAX
0001313397
Rodgers Richard J
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (Right to buy)
23.02
2022-10-29
4
A
0
17095
0.00
A
2023-10-29
2032-10-29
Common Stock
17095
17095
D
Restricted Stock Units
2022-10-29
4
A
0
11400
0.00
A
Common Stock
11400
11400
D
The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the October 29, 2022 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2022-11-01